Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission-Reference-Cited by-同舟云学术

Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission

Published:2021-10-20 Issue:1 Volume:57 Page:95-105
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Tien Feng-Ming^ORCID,Tsai Cheng-Hong^ORCID,Huang Sheng-Chuan,Liu Jia-Hau,Chen Chien-Yuan,Kuo Yuan-Yeh,Chuang Yi-Kuang,Tseng Mei-Hsuan,Peng Yen-Ling,Liu Ming-Chih,Liu Chia-Wen,Liao Xiu-Wen,Lin Liang-In,Wu Yu-Sin,Hou Mei-Fang,Wu Shang-Ju,Hsu Szu-Chun,Ko Bor-Sheng,Chou Wen-Chien^ORCID,Yao Ming,Hou Hsin-An,Tang Jih-Luh^ORCID,Tien Hwei-Fang^ORCID

Funder

Ministry of Science and Technology, Taiwan

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01454-z.pdf

Reference42 articles.

1. Brandts CH, Sargin B, Rode M, Biermann C, Lindtner B, Schwable J, et al. Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation. Cancer Res. 2005;65:9643–50.

2. Pratz KW, Levis M. How I treat FLT3-mutated AML. Blood. 2017;129:565–71.

3. Marcucci G, Haferlach T, Dohner H. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. J Clin Oncol. 2011;29:475–86.